| Name | Title | Contact Details |
|---|
Eisenhower Medical Center was founded over 30 years ago based on a vision of excellence. It is our personal mission to sustain this vision by making Five Star Treatment for Everyone a day-to-day reality — not just a slogan.
HCA Midwest offers a superior level of medical care with 12 state-of-the-art diagnostic and treatment facilities providing a broad range of emergency, outpatient and wellness services as well as acute- and post-acute care.
Wellpoint Health Services is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Serving Southeastern Wisconsin since 1974, Home Care Medical, Inc. provides home infusion, enteral nutrition and hospice care; rehab technology; respiratory care; home medical equipment and supplies; and bracing and compression garments. In addition to the Corporate Headquarters located at 5665 South Westridge Drive in New Berlin, Wisconsin, Home Care Medical, Inc. has three retail store locations at 4818 South 76th Street in Milwaukee, Wisconsin; 2922 South Business Drive in Sheboygan, Wisconsin; and 1709 South 18th Avenue in West Bend, Wisconsin. Home Care Medical, Inc. is the WAMES (Wisconsin Association of Medical Equipment Services) HME Provider of the Year award recipient in 2013 and 2012. Accredited by the Joint Commission and an active member of WAMES, the MedGroup and AAHomecare, Home Care Medical’s mission is to enhance the lives of those we serve.
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.